BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31558784)

  • 21. Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization.
    Chu YH; Wirth LJ; Farahani AA; Nosé V; Faquin WC; Dias-Santagata D; Sadow PM
    Mod Pathol; 2020 Dec; 33(12):2458-2472. PubMed ID: 32737449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pancreatic acinar cell carcinomas with prominent ductal differentiation: Mixed acinar ductal carcinoma and mixed acinar endocrine ductal carcinoma.
    Stelow EB; Shaco-Levy R; Bao F; Garcia J; Klimstra DS
    Am J Surg Pathol; 2010 Apr; 34(4):510-8. PubMed ID: 20182344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ALK, ROS1 and RET rearrangements in lung squamous cell carcinoma are very rare.
    Zhao W; Choi YL; Song JY; Zhu Y; Xu Q; Zhang F; Jiang L; Cheng J; Zheng G; Mao M
    Lung Cancer; 2016 Apr; 94():22-7. PubMed ID: 26973202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NCOA4-RET and TRIM27-RET Are Characteristic Gene Fusions in Salivary Intraductal Carcinoma, Including Invasive and Metastatic Tumors: Is "Intraductal" Correct?
    Skálová A; Ptáková N; Santana T; Agaimy A; Ihrler S; Uro-Coste E; Thompson LDR; Bishop JA; Baněčkova M; Rupp NJ; Morbini P; de Sanctis S; Schiavo-Lena M; Vanecek T; Michal M; Leivo I
    Am J Surg Pathol; 2019 Oct; 43(10):1303-1313. PubMed ID: 31162284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncogenic Properties of the Antisense lncRNA
    Esposito R; Esposito D; Pallante P; Fusco A; Ciccodicola A; Costa V
    Cancer Res; 2019 May; 79(9):2124-2135. PubMed ID: 30862713
    [No Abstract]   [Full Text] [Related]  

  • 26. Fluorescence in situ hybridization to visualize genetic abnormalities in interphase cells of acinar cell carcinoma, ductal adenocarcinoma, and islet cell carcinoma of the pancreas.
    Dewald GW; Smyrk TC; Thorland EC; McWilliams RR; Van Dyke DL; Keefe JG; Belongie KJ; Smoley SA; Knutson DL; Fink SR; Wiktor AE; Petersen GM
    Mayo Clin Proc; 2009 Sep; 84(9):801-10. PubMed ID: 19720778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical, genetic, and immunohistochemical characterization of 70 Ukrainian adult cases with post-Chornobyl papillary thyroid carcinoma.
    Dinets A; Hulchiy M; Sofiadis A; Ghaderi M; Höög A; Larsson C; Zedenius J
    Eur J Endocrinol; 2012 Jun; 166(6):1049-60. PubMed ID: 22457234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spindle Cell Tumors With RET Gene Fusions Exhibit a Morphologic Spectrum Akin to Tumors With NTRK Gene Fusions.
    Antonescu CR; Dickson BC; Swanson D; Zhang L; Sung YS; Kao YC; Chang WC; Ran L; Pappo A; Bahrami A; Chi P; Fletcher CD
    Am J Surg Pathol; 2019 Oct; 43(10):1384-1391. PubMed ID: 31219820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of RET (rearranged during transfection) variants and their downstream signal molecules in RET rearranged lung adenocarcinoma patients.
    Kim JO; Shin JY; Kim MY; Son KH; Jung CK; Kim TJ; Kim SY; Park JK; Sung SW; Bae SJ; Min HJ; Kang JH
    Surg Oncol; 2018 Mar; 27(1):106-113. PubMed ID: 29549897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatoblastomas and mixed and pure acinar cell carcinomas share epigenetic signatures distinct from other neoplasms of the pancreas.
    Benhamida JK; Vyas M; Tanaka A; Wang L; Bahrami A; Ozcan K; Basturk O; Villafania L; Mata DA; El Jabbour T; Selenica P; Roehrl MHA; Weigelt B; Reis-Filho JS; Scaltriti M; Klimstra DS
    Mod Pathol; 2022 Jul; 35(7):956-961. PubMed ID: 34969956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RET/PTC rearrangement is prevalent in follicular Hürthle cell carcinomas.
    de Vries MM; Celestino R; Castro P; Eloy C; Máximo V; van der Wal JE; Plukker JT; Links TP; Hofstra RM; Sobrinho-Simões M; Soares P
    Histopathology; 2012 Nov; 61(5):833-43. PubMed ID: 22803838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Molecular analysis of structural abnormalities in papillary thyroid carcinoma gene].
    Vasil'ev EV; Rumiantsev PO; Saenko VA; Il'in AA; Poliakova EIu; Nemtsova MV; Zaletaev DV
    Mol Biol (Mosk); 2004; 38(4):642-53. PubMed ID: 15456136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RET fusions in a small subset of advanced colorectal cancers at risk of being neglected.
    Pietrantonio F; Di Nicolantonio F; Schrock AB; Lee J; Morano F; Fucà G; Nikolinakos P; Drilon A; Hechtman JF; Christiansen J; Gowen K; Frampton GM; Gasparini P; Rossini D; Gigliotti C; Kim ST; Prisciandaro M; Hodgson J; Zaniboni A; Chiu VK; Milione M; Patel R; Miller V; Bardelli A; Novara L; Wang L; Pupa SM; Sozzi G; Ross J; Di Bartolomeo M; Bertotti A; Ali S; Trusolino L; Falcone A; de Braud F; Cremolini C
    Ann Oncol; 2018 Jun; 29(6):1394-1401. PubMed ID: 29538669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concomitant BRAF(V600E) mutation and RET/PTC rearrangement is a frequent occurrence in papillary thyroid carcinoma.
    Guerra A; Zeppa P; Bifulco M; Vitale M
    Thyroid; 2014 Feb; 24(2):254-9. PubMed ID: 23806056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytomorphologic, immunophenotypical and molecular features of pancreatic acinar cell carcinoma.
    Sun T; Gilani S; Jain D; Cai G
    Diagn Cytopathol; 2023 Nov; 51(11):674-683. PubMed ID: 37469257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncocytic intraductal carcinoma of salivary glands: a distinct variant with TRIM33-RET fusions and BRAF V600E mutations.
    Bishop JA; Nakaguro M; Whaley RD; Ogura K; Imai H; Laklouk I; Faquin WC; Sadow PM; Gagan J; Nagao T
    Histopathology; 2021 Sep; 79(3):338-346. PubMed ID: 33135196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes.
    Drilon A; Hu ZI; Lai GGY; Tan DSW
    Nat Rev Clin Oncol; 2018 Mar; 15(3):151-167. PubMed ID: 29134959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fusion genes in pancreatic tumors.
    Gkountakos A; Singhi AD; Westphalen CB; Scarpa A; Luchini C
    Trends Cancer; 2024 May; 10(5):430-443. PubMed ID: 38378317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cut-off level for RET/PTC rearrangements.
    Colato C; Vicentini C; Cantara S; Pedron S; Brazzarola P; Marchetti I; Di Coscio G; Chilosi M; Brunelli M; Pacini F; Ferdeghini M
    Eur J Endocrinol; 2015 May; 172(5):571-82. PubMed ID: 25698220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraductal carcinoma of the salivary gland with NCOA4-RET: expanding the morphologic spectrum and an algorithmic diagnostic approach.
    Fisch AS; Laklouk I; Nakaguro M; Nosé V; Wirth LJ; Deschler DG; Faquin WC; Dias-Santagata D; Sadow PM
    Hum Pathol; 2021 Aug; 114():74-89. PubMed ID: 33991527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.